Week of September 30 – October 7, 2026
An Emory recruiting update, three ongoing studies, three Field Notes from the archive, and an FDA request for input on ibogaine research.
New here? The Debrief is Psychedelic Vets’ weekly two-minute read on veteran-relevant psychedelic research — what is recruiting, what completed studies found, and what is worth understanding next.
Featured study
A veteran-led study documenting how veterans actually use microdosing — a qualitative look at real experience, not a clinical trial. If you’re a U.S. veteran, a short screening will tell you whether you’re a fit.
Take the 5-minute screening →1Recruiting update
A current ClinicalTrials.gov listing, not a newly registered or newly opened study. Recruiting status checked October 7; the research team determines eligibility.
2Still recruiting
Three ongoing studies from the directory. Recruiting status checked October 7; each study has additional eligibility criteria. PIVOT is now listed as recruiting rather than upcoming in our directory; this corrects an older listing and is not a new opening this week.
3Field Notes — from the archive
Three selections from the published Field Notes archive, with their study designs and limitations. These are not new findings from this week.
4One thing worth knowing
FDA published a request for information on the design and safety of early-phase ibogaine trials (docket FDA-2026-N-10429; comments due Nov 20, 2026). It is a request for public input — not evidence that ibogaine works, not an FDA approval, and not a call for participants.
Read the FDA notice →
The week in veteran psychedelic research — what's newly recruiting, what the latest studies found, and one thing worth knowing. A two-minute read, every Wednesday.
Joining never enrolls you in a study — that always happens with the research team.